表紙
市場調查報告書

褥瘡:開發中產品分析

Pressure Ulcers - Pipeline Review, H2 2019

出版商 Global Markets Direct 商品編碼 465223
出版日期 內容資訊 英文 28 Pages
訂單完成後即時交付
價格
Back to Top
褥瘡:開發中產品分析 Pressure Ulcers - Pipeline Review, H2 2019
出版日期: 2019年09月23日內容資訊: 英文 28 Pages
簡介

所謂褥瘡是破壞皮膚和下層組織的損傷。最容易發病的部位是沒有被大量體脂肪覆蓋並且直接接觸床或車椅的支撐面的部位。原因包括持續的壓力,摩擦和挫傷。治療包括抗生素和營養劑。

本報告提供褥瘡的治療藥開發平台現狀及最新更新的各開發階段比較分析,提供您涵括最新的新聞和發表之企業和研究機關開發中治療藥,治療藥評估,後期階段及中止的計劃等相關資訊。

簡介

  • 調查範圍

褥瘡;概要

治療藥的開發

  • 開發中產品;概要
  • 各企業的產品
  • 企業開發中的產品

治療藥的評估

  • 標的別
  • 各作用機制
  • 各給藥途徑
  • 各分子類型

開發治療藥的企業

  • EyeGene Inc
  • Izun Pharmaceuticals Corp
  • MediWound Ltd
  • NovaLead Pharma Pvt Ltd
  • RegeneRx Biopharmaceuticals Inc
  • RMB-Research GmbH

藥物簡介

  • AG-100
  • EG-Decorin
  • EscharEx
  • IZN-6D4
  • NLP-328
  • RGN-137
  • Statmicoll
  • 面向褥瘡幹細胞療法

暫停中的計劃

開發中止的產品

產品開發的里程碑

  • 主要消息和新聞稿

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC11391IDB

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pressure Ulcers - Pipeline Review, H2 2019, provides an overview of the Pressure Ulcers (Dermatology) pipeline landscape.

Pressure ulcers are an injury that breaks down the skin and underlying tissue. The parts of the body most at risk of developing pressure ulcers are those that are not covered by a large amount of body fat and are in direct contact with a supporting surface (bed or a wheelchair). Causes include continuous pressure, friction and shear. Treatment includes antibiotics and nutrition.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Pressure Ulcers - Pipeline Review, H2 2019, provides comprehensive information on the therapeutics under development for Pressure Ulcers (Dermatology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Pressure Ulcers (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Pressure Ulcers and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II and Preclinical stages are 2 and 3 respectively.

Pressure Ulcers (Dermatology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

  • The pipeline guide provides a snapshot of the global therapeutic landscape of Pressure Ulcers (Dermatology).
  • The pipeline guide reviews pipeline therapeutics for Pressure Ulcers (Dermatology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Pressure Ulcers (Dermatology) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Pressure Ulcers (Dermatology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Pressure Ulcers (Dermatology)

Reasons to buy

  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Pressure Ulcers (Dermatology).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Pressure Ulcers (Dermatology) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Contents

List of Tables

List of Figures

  • Introduction
  • Global Markets Direct Report Coverage
  • Pressure Ulcers - Overview
  • Pressure Ulcers - Therapeutics Development
  • Pipeline Overview
  • Pipeline by Companies
  • Products under Development by Companies
  • Pressure Ulcers - Therapeutics Assessment
  • Assessment by Target
  • Assessment by Mechanism of Action
  • Assessment by Route of Administration
  • Assessment by Molecule Type
  • Pressure Ulcers - Companies Involved in Therapeutics Development
  • EyeGene Inc
  • MimeTech Srl
  • NovaLead Pharma Pvt Ltd
  • Shionogi & Co Ltd
  • Pressure Ulcers - Drug Profiles
  • EG-Decorin - Drug Profile
  • Product Description
  • Mechanism Of Action
  • R&D Progress
  • MT-8 - Drug Profile
  • Product Description
  • Mechanism Of Action
  • R&D Progress
  • NLP-328 - Drug Profile
  • Product Description
  • Mechanism Of Action
  • R&D Progress
  • SR-0379 - Drug Profile
  • Product Description
  • Mechanism Of Action
  • R&D Progress
  • Stem Cell Therapy for Pressure Ulcers - Drug Profile
  • Product Description
  • Mechanism Of Action
  • R&D Progress
  • Pressure Ulcers - Dormant Projects
  • Pressure Ulcers - Discontinued Products
  • Appendix
  • Methodology
  • Coverage
  • Secondary Research
  • Primary Research
  • Expert Panel Validation
  • Contact Us
  • Disclaimer

List of Tables

  • Number of Products under Development for Pressure Ulcers, H2 2019
  • Number of Products under Development by Companies, H2 2019
  • Products under Development by Companies, H2 2019
  • Number of Products by Stage and Target, H2 2019
  • Number of Products by Stage and Mechanism of Action, H2 2019
  • Number of Products by Stage and Route of Administration, H2 2019
  • Number of Products by Stage and Molecule Type, H2 2019
  • Pressure Ulcers - Pipeline by EyeGene Inc, H2 2019
  • Pressure Ulcers - Pipeline by MimeTech Srl, H2 2019
  • Pressure Ulcers - Pipeline by NovaLead Pharma Pvt Ltd, H2 2019
  • Pressure Ulcers - Pipeline by Shionogi & Co Ltd, H2 2019
  • Pressure Ulcers - Dormant Projects, H2 2019
  • Pressure Ulcers - Discontinued Products, H2 2019

List of Figures

  • Number of Products under Development for Pressure Ulcers, H2 2019
  • Number of Products under Development by Companies, H2 2019
  • Number of Products by Stage and Targets, H2 2019
  • Number of Products by Stage and Mechanism of Actions, H2 2019
  • Number of Products by Routes of Administration, H2 2019
  • Number of Products by Stage and Routes of Administration, H2 2019
  • Number of Products by Molecule Types, H2 2019
  • Number of Products by Stage and Molecule Types, H2 2019
Back to Top